ASHLEY EDMUNDS-ALFIERI: Open Payments
NPI 1992435671 · AUBURN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$591 in 38 payments from 10 companies in 2025. Trend: 2023 $213 · 2024 $562 · 2025 $591
Food & beverage: $591
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $180 |
| Novo Nordisk Inc | 10 | $159 |
| Lilly USA, LLC | 5 | $89 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
| IBSA Pharma Inc. | 2 | $30 |
| ABBVIE INC. | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| PFIZER INC. | 1 | $16 |
Products named: Kerendia, MOUNJARO, Rybelsus, Wegovy, AIRSUPRA, Tirosint, Ozempic, UBRELVY.
Industry payments across NY — which companies pay providers there.
